Side by Side – Dexcom G6 (left) and G7 (right)
Dexcom’s G7 is the next-generation continuous glucose monitoring (CGM) system building on the best-selling real-time CGM in the world. It is now more powerful and easier to use with a small, all-in-one wearable and completely redesigned mobile app. The new system will have the fastest sensor warm-up on the market, with no fingersticks or scanning required. Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range (TIR).
The CE Mark (Conformité Européenne) for Dexcom G7 CGM system for people with diabetes in Europe age two years and older, includes use by pregnant women too.
It offers people with diabetes a better way to gain greater control, managing it more confidently each day. Its low-profile, all-in-one wearable sends real-time glucose readings automatically to a compatible smart device or receiver. It offers a suite of customizable alerts that can warn of high or low glucose levels and help users spend more time in range. Industry-leading remote monitoring and reporting capabilities also allow them to stay connected with their loved ones and care teams anytime, anywhere.
“Today marks an incredible milestone for our company and for people with diabetes in Europe,” said Kevin Sayer, chairman, president and CEO of Dexcom. “This all-new platform offers an incredibly powerful CGM that is simple to use, providing our users with insightful glucose data on one screen that helps them spend less time managing diabetes and more time doing the things they love. Dexcom G7 takes everything people love about G6 and makes it even better.”
Dexcom expects to initiate a launch of Dexcom G7 in Europe in the next weeks anad months. The company also plans to introduce an updated CGM algorithm in 2022, driving the next step forward in CGM sensor performance.
Visit Dexcom.com and get started with Dexcom G6 today to experience the benefits of CGM now. To learn more about Dexcom G7 and for additional information about when it will be available in Europe, visit Dexcom.com/G7
